Lukas Been

Dr. Lukas Been is a surgical oncologist at the University Medical Center Groningen (UMCG), part of the Faculty of Medical Sciences at the University of Groningen. With extensive expertise in surgical oncology, melanoma, sarcoma, testicular cancer, and HIPEC (Hyperthermic Intraperitoneal Chemotherapy), Dr. Been serves as a Surgical Oncology Educator and Examiner for Professional Development in the Master's program.

Dr. Been's research focuses on soft tissue sarcomas, melanoma, and complex surgical oncology procedures. His work spans diagnostic approaches, surgical techniques including limb preservation strategies, metastasectomy outcomes, and biomarker research for melanoma surveillance. He has made significant contributions to understanding treatment complications, quality of life outcomes, and economic aspects of cancer care.

His recent publications demonstrate a strong emphasis on advancing sarcoma management through innovative approaches like pandemic-adapted radiotherapy protocols, three-dimensional tumor modeling for surgical planning, and consensus guidelines for isolated limb perfusion. In melanoma research, he has critically evaluated biomarkers like S100B for recurrence detection and investigated systemic therapy timing in advanced disease.

Dr. Been actively participates in international research collaborations, contributing to multicenter studies and systematic reviews that shape clinical practice in surgical oncology. His work frequently appears in high-impact journals including European Journal of Cancer, British Journal of Surgery, and European Journal of Surgical Oncology.

As an educator, Dr. Been plays a key role in training the next generation of surgical oncologists and serves as an examiner for advanced medical students. His clinical practice focuses on providing specialized surgical care for complex oncological conditions while advancing the field through rigorous research and scholarly activity.